Viewpoint: Why do we need a point-of-care CD4 test for low-income countries?
AffiliationMédecins sans Frontières, Operational Centre Brussels; CD4 Initiative, Institute for Global Health, UK; Clinton Health Access Initiative, Liberia; Department of HIV/AIDS, Ministry of Health, Malawi; Management Sciences for Health, Malawi; International Union against Tuberculosis and Lung Disease, France; London School of Hygiene and Tropical Medicine, UK
MetadataShow full item record
AbstractIn this paper, we discuss the reasons why we urgently need a point-of-care (POC) CD4 test, elaborate the problems we have experienced with the current technology which hampers CD4-count coverage and highlight the ideal characteristics of a universal CD4 POC test. It is high-time that CD4 technology is simplified and adapted for wider use in low-income countries to change the current paradigm of restricted access once and for all.
- Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
- Authors: Elliott JH, Lynen L, Calmy A, De Luca A, Shafer RW, Zolfo M, Clotet B, Huffam S, Boucher CA, Cooper DA, Schapiro JM
- Issue date: 2008 Oct 18
- Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire.
- Authors: Diabaté S, Alary M
- Issue date: 2009 Nov
- The use of total lymphocyte count (TLC) as an independent criterion for initiating HAART in resource-poor countries.
- Authors: Lee SS, Wong KH
- Issue date: 2005 Jan
- Antiretroviral therapy: unmet need and associated socio-demographic characteristics among HIV-positive women in Haiphong, Vietnam.
- Authors: Nam NT, Bygbjerg IC, Mogensen HO, Rasch V
- Issue date: 2011 Jan
- Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries.
- Authors: Souteyrand YP, Collard V, Moatti JP, Grubb I, Guerma T
- Issue date: 2008 Jul